-+ 0.00%
-+ 0.00%
-+ 0.00%

TMC Life Sciences adds named CEO remuneration disclosure to 2026 annual report

PUBT·11/20/2026 10:06:01
TMC Life Sciences adds named CEO remuneration disclosure to 2026 annual report
  • TMC Life Sciences amended its 2026 annual report to add named remuneration disclosure for its group chief executive officer.
  • Three senior executives received above RM 500,000 each; two received between RM 250,000 and RM 500,000 for the year ended June 30, 2026.
  • Salaries and bonuses represented 89% of remuneration in both groups; other remuneration accounted for 11%.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. TMC Life Sciences Bhd published the original content used to generate this news brief via Bursa Malaysia (KLSE) (Ref. ID: 3726720) on November 20, 2026, and is solely responsible for the information contained therein.